Match Document Document Title
US20110171201 Formulation for Oral Administration of Proteins  
Pharmaceutical formulations of orally administered proteins can be stabilized from oxidative degradation and inactivation in the stomach and GI tract by the addition of an antioxidant.
US20130287756 COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN  
Beneficial and synergistic effects for alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis have been found with krill oil and/or marine oil in combination with other...
US20110020316 COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN  
Beneficial and synergistic effects for alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis have been found with krill oil and/or marine oil in combination with other...
US20130315890 Extramuscular treatment of traumatic-induced migraine headache  
A method for selection and treatment of externally caused migraine headache, the method includes identifying a patient group having chronic migraine headache; determining the identified patient...
US20110189159 METHODS AND COMPOSITIONS FOR PROTEIN DELIVERY  
The present invention provides methods and compositions for protein delivery. The invention features virus like particles, methods of making virus like particles and methods of using virus like...
US20110076316 SCALABLE MATRIX FOR THE IN VIVO CULTIVATION OF BONE AND CARTILAGE  
The present invention provides implantable receptacle devices (and methods) for use in bone and tissue regeneration which provide immediate structural stability and strength to a zone where tissue...
US20150231068 Treatment of Migraine Headaches with Presynaptic Neurotoxin  
The present invention provides a method for treating a patient for migraine headache, including symptoms associated with migraine headache, such as migraine associated vertigo, which comprises...
US20110318329 METHOD OF TREATMENT OR PROPHYLAXIS  
The present invention is directed to methods and agents that are useful in the prevention and amelioration of signs and symptoms associated with neuropathic conditions. More particularly, the...
US20130236444 TREATMENT OF MIGRAINE HEADACHE WITH DIFFUSION OF TOXIN IN NON-MUSCLE RELATED FORAMINAL SITES  
A method for treating a patient with migraine headache includes administering to the patient a therapeutically effective amount of an invertebrate presynaptic neurotoxin in a pharmaceutically safe...
US20120114628 COSMETIC AND THERAPEUTIC USE OF PROTEINS OF DJ-1 TYPE FOR TREATING SKIN DRYNESS  
The present invention relates to the use, especially the cosmetic and/or therapeutic use, of the protein DJ-1, of polypeptides derived from this protein or of analogues thereof, of a nucleic acid...
US20110243937 TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER  
The present application provides methods of prevention and/or treatment of breast cancer in a subject by inhibiting expression of PAX2. In the cancer treatment methods disclosed, the method of...
US20110305633 Methods for Treatment, the Prognostic Assessment and the Detection of Breast Cancer  
The present invention relates to methods for the treatment, the prognostic assessment and the detection of breast cancer.
US20140328818 Proteases for Degrading Gluten  
Gluten-degrading proteases derived from insects, including flour beetles, are isolated, and the purified, and recombinant forms can be used to make gluten-containing food safe for patients...
US20130045195 Proteases for Degrading Gluten  
Gluten-degrading proteases derived from insects, including flour beetles, are isolated, and the purified, and recombinant forms can be used to make gluten-containing food safe for patients...
US20110300161 Methods for the Treatment and the Prognostic Assessment of Malignant Pleural Mesothelioma  
The present invention relates to methods for the treatment and the prognostic assessment of malignant pleural mesothelioma.
US20140010802 SYSTEMS AND METHODS FOR DIAGNOSING A PREDISPOSITION TO DEVELOP CANCER  
Systems, methods, and computer readable media for diagnosing or characterizing a genetic predisposition to develop cancer, including cancers of the BAP1 cancer syndrome, are provided. Nucleic...
US20100303798 Methods of Treating Urogenital-Neurological Disorders Using Neurotrophin Retargeted Endopepidases  
The present specification discloses TVEMPs, compositions comprising such toxins and methods of treating urogenital-neurological disorders in a mammal using such TVEMPs and compositions.
US20110274682 METHODS FOR PROTEASE ASSISTED PROTEIN DELIVERY  
A method for intracellular delivery of single proteins or other cargo molecules by encapsulation within nanocapsules formed by interfacial polymerization of one or more types of monomers and...
US20120093802 BIOACTIVE COMPOSITION INCLUDING STABILIZED PROTEIN AND PROCESS FOR PRODUCING THE SAME  
A bioactive composition includes a porous hydrogel matrix. At least one protein is immobilized in the porous hydrogel matrix forming a hydrogel protein composite that is stable in an organic...
US20140086867 Systems, Compositions and Methods for the Treatment of Alopecia  
A method of inducing or promoting hair growth on the scalp of a subject, comprising the steps of (i) providing an ECM composition including at least one ECM material, (ii) administering inciting...
US20140248258 METHODS FOR IMPROVING GUT HEALTH  
The present invention provides methods for improving gut health. In particular, the invention provides methods for improving gut health by improving the digestibility of dietary proteins,...
US20120225050 METHODS FOR IMPROVING GUT HEALTH  
The present invention provides methods for improving gut health. In particular, the invention provides methods for improving gut health by improving the digestibility of dietary proteins,...
US20150118154 METHODS FOR THE TREATMENT, THE PROGNOSTIC ASSESSMENT AND THE STAGING OF NON-SMALL CELL LUNG CANCER  
The present invention relates to methods for the treatment, the prognosis and the diagnosis of non-small cell lung cancer.
US20130224172 METHODS OF TREATING BEHAVIORAL SYMPTOMS OF NEUROLOGICAL AND MENTAL DISORDERS  
Disclosed herein are methods of using coated digestive enzyme preparations and enzyme delivery systems and pharmaceutical compositions comprising the preparations for treatment of subjects having...
US20120156253 Enzyme Treatment of Foodstuffs for Celiac Sprue  
Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects...
US20110293724 Enzyme Treatment of Foodstuffs for Celiac Sprue  
Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects...
US20100310544 COMPOSITION COMPRISING CALCIUM IONS AND AT LEAST ONE PROTEOLYTIC ENZYME FOR USE IN THE IN VITRO AND IN VIVO REGENERATION OF CUTANEOUS AND CONNECTIVE TISSUES  
The invention is based on the finding that calcium ions and proteolytic enzymes, particularly papain, act in a synergetic way in the regeneration of skin and connective tissues. Thus, such a...
US20140148642 Magic genie developer  
Apparatus and formulations for correcting and curing erectile dysfunction in men to create a natural erection without the use of primitive devices. the formulations will correct and cure erectile...
US20150023949 COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER  
Methods for treatment and diagnosis of pervasive developmental disorders in humans are described.
US20130224178 Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopepidases  
The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer in a mammal using such TVEMP compositions.
US20130166040 REAGENTS AND METHODS FOR PREPARING TEETH FOR IMPLANTATION  
The invention provides reagents and method for replacing teeth lost to periodontitis and other diseases and disorders resulting in tooth loss, and provides materials and methods that result in...
US20120076768 DIGESTIVE/LAXATIVE COMPOSITIONS  
Described are digestive/laxative compositions and methods of manufacture and use of same. In a preferred embodiment, the invention provides for a digestive/laxative composition including...
US20110318342 METHODS OF USING IL-1 ANTAGONISTS TO TREAT AUTOINFLAMMATORY DISEASE  
Methods of treating, inhibiting, or ameliorating an autoinflammatory disorder, disease, or condition in a subject in need thereof, comprising administering to a subject in need a therapeutic...
US20110076260 Proteases Producing an Altered Immunogenic Response and Methods of Making and Using the Same  
The present invention provides novel protein variants that exhibit reduced immunogenic responses, as compared to the parental proteins. The present invention further provides DNA molecules that...
US20140335046 Compositions, Methods and Systems for Regenerative Cosmetics  
A method of inducing or promoting hair growth on the scalp of a subject, comprising the steps of (i) providing an ECM composition including at least one ECM material, (ii) administering inciting...
US20140219954 DRY POWDER FORMULATIONS OF ORGANIC MACROMOLECULES  
The present invention relates to methods for making a stabilized powder formulation for inhalation comprising a macromolecule in lyophilized form, a crystalline carrier material, and magnesium...
US20110123573 Methods and compositions for treating phenylketonuria  
Provided herein are methods for treating a subject suffering from phenylketonuria by administering a phenylalanine hydroxylase (“PAH”) and/or a phenylalanine ammonia lyase (“PAL”) to the subject...
US20120230976 ROTHIA SPECIES GLUTAMINE ENDOPEPTIDASES AND USE THEREOF  
Disclosed are glutamine endopeptidase enzymes from Rothia sp. bacteria that are naturally associated with the oral cavity, formulations comprising the glutamine endopeptidase enzymes and the use...
US20080206224 MUSCLE CONTRACTION TREATMENT UTILIZING BOTULINUM TOXIN  
The invention provides for the use of a botulinum toxin to treat contracture, such as muscle contracture, in patients by transdermal administration of the botulinum toxin.
US20140120077 Compositions and Methods for Safe Treatment of Rhinitis  
Methods for treating rhinitis in a subject are provided herein. The methods of the present invention comprise intranasal administration of a topical composition comprising a purified botulinum...
US20110086017 Medical Food composition and methods for management of inflammatory processes in mammals  
A medical food composition, containing at least source of milk protein derived from milk producing animals, exposed to immune stimulants during pregnancy and lactation period, source of...
US20110117074 METHODS OF TREATING HIV AND INFLUENZA INFECTIONS USING ASPERGILLUS ORYZAE PROTEASE  
The invention provides methods for treating viral diseases such as HIV infection and influenza infection in a subject in need of treatment, comprising orally administering to the subject a...
US20120244140 SCREENING METHOD FOR SUBSTANCE CAPABLE OF PROMOTING RECOVERY OF SKIN BARRIER FUNCTION TECHNICAL FIELD  
The present invention provides a screening method for a substance capable of promoting recovery of skin barrier function, wherein the method comprises the steps of incubating caspase-14 and...
US20110020270 TREATMENT AND PROPHYLAXIS  
This invention discloses the use of an E-selectin antagonist and a mobilizer of hematopoietic stem cells or progenitor cells in methods and compositions for treating or preventing...
US20110177056 NON-CYTOTOXIC FUSION PROTEINS COMPRISING EGF MUTEINS  
The present invention relates to fusion proteins comprising a non-cytotoxic protease and a EGF mutein ligand. The EGF mutein provides improved EGF receptor activation for the claimed fusion...
US20110020315 TREATMENT OF INFLAMMATORY ILLNESSES WITH ACE2  
The present invention relates to ACE2 for the therapeutic treatment or prevention of inflammation.
US20110044999 IL-32 MODULATORS  
The present invention relates to methods of screening for modulators of interleukin 32 (IL-32), to modulators of IL-32 and to their use.
US20120321611 Replenishment and Enrichment of Ocular Surface Lubrication  
An ophthalmic composition, and methods of use thereof, including for treating ocular boundary deficiency, symptoms associated therewith, or undesired condition that is associated with or causes...
US20110130783 TREATMENT OF OBESITY AND RELATED DISORDERS  
This disclosure provides a method of treating obesity and related disorders through the administration of a composition comprising a neurotoxin and a mucosal permeabilizing agent. Methods for...
US20120121612 FERMENTED WHEAT GERM PROTEINS (FWGP) FOR THE TREATMENT OF CANCER  
The present invention provides compositions comprising the component of fermented wheat germ extract (“FWGE”) active in reducing, inhibiting or preventing the proliferation of cancer cells and/or...